We are live on ! Find out more
SCM

Scopia Capital Management Portfolio holdings

AUM $146M
1-Year Est. Return 25.93%
This Fund
S&P 500
This Quarter Est. Return
+10.63%
1 Year Est. Return
+25.93%
3 Year Est. Return
+30.87%
5 Year Est. Return
+45.28%
10 Year Est. Return
+379.83%
AUM
$5.67B
AUM Growth
+$826M
Cap. Flow
+$457M
Cap. Flow %
8.07%
Top 10 Hldgs %
63.6%
Holding
49
New
6
Increased
17
Reduced
9
Closed
8

Sector Composition

Rank Sector Weight
1 Healthcare 28.21%
2 Industrials 19.37%
3 Technology 10.12%
4 Communication Services 9.61%
5 Real Estate 7.33%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SPR
1
DELISTED
Spirit AeroSystems
SPR
$565M 9.96%
12,676,625
-96,027
-0.8% -$4.24M
UTHR icon
2
United Therapeutics
UTHR
$26.1B
$483M 8.52%
4,092,701
-208,651
-5% -$25.1M
FCE.A
3
DELISTED
Forest City Realty Trust, Inc.
FCE.A
$415M 7.33%
17,963,247
-23,893
-0.1% -$558K
IWM icon
4
PUT
iShares Russell 2000 ETF
IWM
$79.1B
$366M 6.46%
2,946,600
+1,383,300
+88% +$168M
SPY icon
5
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$771B
$359M 6.34%
1,661,000
+1,044,800
+170% +$226M
BIDU icon
6
Baidu
BIDU
$35.7B
$355M 6.25%
1,947,485
-202,065
-9% -$35M
PRGO icon
7
Perrigo
PRGO
$1.44B
$279M 4.92%
3,022,503
+1,061,026
+54% +$97.8M
JCI icon
8
Johnson Controls International
JCI
$85.1B
$279M 4.92%
5,992,261
+3,544,098
+145% +$164M
ITRI icon
9
Itron
ITRI
$4.54B
$254M 4.48%
4,558,387
+83,303
+2% +$3.99M
GWPH
10
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
$250M 4.41%
1,885,167
+407,458
+28% +$38.9M
JD icon
11
JD.com
JD
$43.5B
$227M 4%
8,693,131
+140,013
+2% +$3.37M
NFLX icon
12
Netflix
NFLX
$307B
$190M 3.36%
19,313,980
+433,120
+2% +$4.13M
WMB icon
13
Williams Companies
WMB
$85.8B
$151M 2.66%
4,899,478
+2,199,938
+81% +$58.4M
IBB icon
14
PUT
iShares Biotechnology ETF
IBB
$9.45B
$138M 2.44%
+1,434,000
New +$136M
ZBRA icon
15
Zebra Technologies
ZBRA
$13.5B
$119M 2.09%
1,704,491
-184,989
-10% -$11.4M
TMX
16
DELISTED
Terminix Global Holdings, Inc.
TMX
$116M 2.04%
5,131,013
+545,380
+12% +$13.7M
DST
17
DELISTED
DST Systems Inc.
DST
$112M 1.98%
1,902,822
-1,179,136
-38% -$71.4M
CNMD icon
18
CONMED
CNMD
$1.3B
$111M 1.96%
2,774,045
INSY
19
DELISTED
Insys Therapeutics, Inc.
INSY
$108M 1.9%
9,129,013
+141,700
+2% +$2.15M
TVTX icon
20
Travere Therapeutics
TVTX
$5.17B
$95.2M 1.68%
4,252,888
+441,067
+12% +$8.4M
FICO icon
21
Fair Isaac
FICO
$31.8B
$88.5M 1.56%
710,230
-492,369
-41% -$61.4M
ACOR
22
DELISTED
Acorda Therapeutics
ACOR
$87.8M 1.55%
35,033
+8,606
+33% +$25.7M
AR icon
23
Antero Resources
AR
$10.9B
$86.4M 1.52%
+3,206,209
New +$85.4M
MYGN icon
24
Myriad Genetics
MYGN
$476M
$75.3M 1.33%
3,659,647
-994,680
-21% -$25.2M
NDRM
25
DELISTED
NeuroDerm Ltd. Ordinary Shares
NDRM
$62.6M 1.1%
3,383,358

Similar funds

Scopia Capital Management's Q3 2016 Portfolio in Review

As of Q3 2016, Scopia Capital Management held 49 positions worth $5.67B, up 17% from $4.84B the previous quarter. Its ten largest holdings account for 64% of the portfolio.

Scopia Capital Management deployed $457M of net new capital in Q3 2016, opening 6 new positions and adding to 17 existing holdings. Its largest new stake was Antero Resources: 3,206,209 shares worth $86.4M.

By sector, the portfolio is most concentrated in Healthcare at 28% of assets, down from 29% a quarter earlier, followed by Industrials and Technology.

On the sell side, the largest reduction was DST Systems Inc., an estimated $71.4M trimmed.

  • Scopia Capital Management's largest Q3 2016 buy was Antero Resources: 3,206,209 shares worth $86.4M.
  • Scopia Capital Management added most to Johnson Controls International in Q3 2016, an estimated $164M increase.
  • Scopia Capital Management's biggest Q3 2016 reduction was DST Systems Inc., cutting an estimated $71.4M.
  • Scopia Capital Management fully exited Sabre in Q3 2016, selling an estimated $184M.
  • Scopia Capital Management's ten largest holdings make up 64% of its $5.67B portfolio in Q3 2016.
  • Scopia Capital Management opened 6 new positions and closed 8 in Q3 2016.
  • Scopia Capital Management's portfolio value rose 17% quarter-over-quarter to $5.67B.

Based on Scopia Capital Management's 13F filing for Q3 2016, filed 14 Nov 2016.